While gaps persist in workforce retention, infrastructure, and equitable access, the transformation of Nigeria’s health ...

Fintel reports that on May 8, 2025, Maxim Group downgraded their outlook for Theriva Biologics (NYSEAM:TOVX) from Buy to Hold. Analyst Price Forecast Suggests 655.56% Upside As of May 7, 2025, the ...

[90] Common drugs associated with IgE-mediated allergies include b-lactam antibiotics (e.g., penicillin and cephalosporin), immunoglobulin preparations (IgA, IgE), pyrazolones, quinolones ...

More information: Niels Vander Elst et al, Bacteriophage-derived endolysins restore antibiotic susceptibility in β-lactam- and macrolide-resistant Streptococcus pneumoniae infections, Molecular ...

VCN-01 Achieves Primary Efficacy and Safety Endpoints for Pancreatic Ductal Adenocarcinoma in VIRAGE Phase 2b Clinical Trial -- Closed a public offering on May 8, 2025, raising the Company's cash ...

The Company intends to use the net proceeds from this Offering primarily for working capital and general corporate purposes, including for research and development and manufacturing scale-up. The ...

Key themes and highlights from ESCMID Global 2025 to support antimicrobial stewardship and best practice in infectious ...

The presence of nitrogen affects the solubility, stability, and bioavailability of a drug, significantly influencing its overall effectiveness as an antibiotic. Application: β-lactam antibiotics ...

An international team of researchers, led by the University of Vienna and the Helmholtz Institute for Pharmaceutical Research ...

The drug – a combination of beta-lactam antibiotic aztreonam with beta-lactamase inhibitor avibactam – is the first monobactam/β-lactamase inhibitor combination to be cleared in the US for ...